Why Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday?
March 14, 2024 at 09:19 AM EDT
Wednesday,Spruce Biosciences Inc(NASDAQ:SPRB) released topline results from its CAHmelia-203 Phase 2b study of tildacerfont ...